申请人:Novartis AG
公开号:US10724006B2
公开(公告)日:2020-07-28
The invention provides lentiviral preparations containing a sulfonic acid buffer, such as 1,4-piperazinediethanesulfonic acid (PIPES), 2-(N-morpholino)ethanesulfonic acid (MES), and 3-morpholinopropane-1-sulfonic acid (MOPS), a sodium citrate buffer, or a phosphate buffer. The invention additionally encompasses methods of lentiviral purification as well as methods of transducing human cells.
本发明提供了含有磺酸缓冲液(如 1,4-哌嗪二乙磺酸(PIPES)、2-(N-吗啉基)乙磺酸(MES)和 3-吗啉丙烷-1-磺酸(MOPS))、柠檬酸钠缓冲液或磷酸盐缓冲液)的慢病毒制剂。本发明还包括慢病毒纯化方法以及转导人体细胞的方法。